| Similar Articles |
|---|
 |
The Motley Fool
October 26, 2006
Jack Uldrich |
Symyx Homes In on the Right Mix New nanomaterials and customers could catalyze the stock of this high-throughput technology and research software company. Investors, this remains one of the better ways to play this sector.   |
The Motley Fool
October 29, 2007
Tom Taulli |
Symyx Still Stymied It has been a gruesome year for shareholders of Symyx Technologies, which develops technologies to manage R&D projects for chemical and life sciences companies. So far this year, the stock price has lost about half its value. |
The Motley Fool
April 29, 2010
David Lee Smith |
Don't Tell Dow Chemical the Economy Is Soft Dow Chemical, a short time from its wild 2009, turns in one powerful quarter. |
Bio-IT World
August 15, 2005
Johan Bostrom |
Symyx System Automates R&D Bay-Area-based research company Symyx Technologies is sharing lessons learned from its experience with lab automation by licensing its software or collaborating with other R&D companies. |
The Motley Fool
October 22, 2009
David Lee Smith |
DuPont Clobbers the Street's Estimates Chemical giant DuPont grew its earnings and proves that the recession might be waning. |
The Motley Fool
October 27, 2005
W.D. Crotty |
One Word: Plastics Dow Chemical reports hearty sales growth for the third quarter. But there is a lot more for long-term investors to investigate. |
The Motley Fool
August 29, 2005
W.D. Crotty |
Chemical Industry Slowing? Railroad loadings of chemicals have declined recently. But investors with a contrarian bent, who would also enjoy a 3.1% dividend yield, should look at Dow Chemical. |
The Motley Fool
December 17, 2007
David Lee Smith |
Dow Chemical Lands a Big One Following a couple of months of speculation, Dow Chemical discloses some big plans. |
The Motley Fool
July 31, 2009
David Lee Smith |
Dow Chemical Calls U.S. Economy's Bottom With all sorts of buying and selling, Dow Chemical nevertheless smacks a solid quarter. |
The Motley Fool
January 31, 2008
Todd Wenning |
Positive Adjectives Abound at Dow The chemical company is looking to grow all over the world. |
The Motley Fool
December 7, 2007
David Lee Smith |
Dow Chemical's Not a Dazzler Yet Dow Chemical is planning a cost-reduction effort that will involve shutting down a number of plants and laying off about 1,000 employees, but the company's direction remains a mystery. |
The Motley Fool
April 25, 2008
David Lee Smith |
Dow Almost Gets It Done Dow Chemical boosts across-the-board sales, but earnings falter. |
The Motley Fool
November 1, 2011
Neha Chamaria |
Wow, Dow!! What a Performance! Why Dow Chemical is a superb chemical stock to have on your stock watchlist. |
The Motley Fool
February 4, 2011
David Lee Smith |
Dow Chemical Is Packing a Punch Not far removed from acquisition difficulties, Dow Chemical posted one powerful quarter. |
The Motley Fool
October 21, 2011
Neha Chamaria |
1 Promising Stock You Shouldn't Miss Dow Chemical looks cheap on an absolute basis, and when compared to its peers on a trailing P/E basis. |
The Motley Fool
May 12, 2009
David Lee Smith |
Dow Chemical Races Back Dow Chemical is wasting no time in shaping up after its Rohm and Haas purchase. |
The Motley Fool
October 3, 2005
W.D. Crotty |
Good News: Dow's Down Dow Chemical's beat-up share price may be a boon to value investors. |
The Motley Fool
February 13, 2007
Selena Maranjian |
Who's in "The Dow"? The Dow is an average based on the stock prices of 30 companies. |
The Motley Fool
October 30, 2010
David Lee Smith |
Dow Chemical Is Hitting on All Cylinders A little more than a year after a big acquisition, Dow Chemical is kicking bottom(s). |
The Motley Fool
November 1, 2004
Rich Smith |
Buy the Dow The only discordant note in Dow Chemical's earnings report came from its cash-flow statement. The company's revenues for the quarter surpassed $10 billion, a 26% increase over Q3 2003. |
Information Today
August 20, 2007
Robert E. Buntrock |
Elsevier to Sell MDL to Symyx Technologies Elsevier buys Beilstein. Elsevier integrates Beilstein into MDL DiscoveryGate. Elsevier sells MDL to Symyx, which had previously purchased IntelliChem and Synthematix. Elsevier keeps Beilstein. These are interesting times in the cheminformatics business. |
BusinessWeek
May 2, 2005
Michael Arndt |
No Longer The Lab Of The World U.S. chemical plants are closing in droves as production heads abroad. |
The Motley Fool
February 4, 2010
Rich Smith |
Dow Chemical Is Nitroglycerine One shake, and it could explode. |
The Motley Fool
October 28, 2011
David Lee Smith |
Dow Chemical Shows Shocking Strength Dow Chemical's share-price U-turn indicates a surprisingly strong quarter. |
The Motley Fool
July 14, 2005
W.D. Crotty |
Earnings Preview: Dow Chemical Dow expects strong second-quarter earnings. Long-term investors should consider that the industry's usual boom-bust cycle may be muted this time. |
The Motley Fool
December 7, 2005
W.D. Crotty |
Get Dow Chemical on the Cheap Its dividend looks good, and most of the cash it's gushing comes from all over the world. Investors, take note. |
The Motley Fool
October 29, 2007
David Lee Smith |
Where Are You Going, Dow Chemical? While Dow Chemical reported a down quarter, the real question investors need to ask is its likely direction. |
The Motley Fool
January 6, 2012
Neha Chamaria |
Dow's Wow Performance in 2011 Great operational performance and growth moves, but subdued stock performance wraps up the year for Dow Chemical. |
The Motley Fool
April 19, 2011
Jordan DiPietro |
Should You Buy and Hold Dow Chemical? Dow has passed only one of our four tests for a good retirement stock, so it may not be the right choice for someone near or entering retirement. |
The Motley Fool
December 16, 2011
Brian Orelli |
Biotech Royalties, Almost as Good as Cash They're flexible, and all royalties have value. |
The Motley Fool
May 19, 2009
David Lee Smith |
The Action Never Stops at Dow Chemical While its shareholders have approved say on pay, Dow also is raising some prices. |
